关注
Nagham Ailabouni
标题
引用次数
引用次数
年份
Challenges and enablers of deprescribing: a general practitioner perspective
NJ Ailabouni, PS Nishtala, D Mangin, JM Tordoff
PloS one 11 (4), e0151066, 2016
2102016
DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities
N Ailabouni, D Mangin, PS Nishtala
International journal of clinical pharmacy 41 (1), 167-178, 2019
1082019
General practitioners’ insight into deprescribing for the multimorbid older individual: a qualitative study
NJ Ailabouni, PS Nishtala, D Mangin, JM Tordoff
International Journal of Clinical Practice 70 (3), 261-276, 2016
712016
Consumer attitudes towards deprescribing: a systematic review and meta-analysis
KR Weir, NJ Ailabouni, CR Schneider, SN Hilmer, E Reeve
The Journals of Gerontology: Series A 77 (5), 1020-1034, 2022
692022
Alterations in drug disposition in older adults: a focus on geriatric syndromes
D Maher, N Ailabouni, AA Mangoni, MD Wiese, E Reeve
Expert opinion on drug metabolism & toxicology 17 (1), 41-52, 2021
502021
Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities
N Ailabouni, D Mangin, PS Nishtala
BMJ open 7 (4), e013800, 2017
352017
COVID-19 pandemic: considerations for safe medication use in older adults with multimorbidity and polypharmacy
NJ Ailabouni, SN Hilmer, L Kalisch, R Braund, E Reeve
The Journals of Gerontology: Series A 76 (6), 1068-1073, 2021
342021
Barriers and enablers of older adults initiating a deprescribing conversation
NJ Ailabouni, KR Weir, E Reeve, JT Turner, JW Norton, SL Gray
Patient Education and Counseling 105 (3), 615-624, 2022
262022
Leveraging implementation science to increase the translation of deprescribing evidence into practice
NJ Ailabouni, E Reeve, CD Helfrich, SN Hilmer, BH Wagenaar
Research in Social and Administrative Pharmacy 18 (3), 2550-2555, 2022
242022
Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: a randomized controlled trial
H Jamieson, PS Nishtala, HU Bergler, SK Weaver, JW Pickering, ...
The Journals of Gerontology: Series A 78 (9), 1692-1700, 2023
192023
Do residents need all their medications? A cross-sectional survey of RNs' views on deprescribing and the role of clinical pharmacists
N Ailabouni, J Tordoff, D Mangin, PS Nishtala
Journal of Gerontological Nursing 43 (10), 13-20, 2017
172017
Examining potentially inappropriate prescribing in residential care using the STOPP/START criteria
NJ Ailabouni, PS Nishtala, JM Tordoff
European Geriatric Medicine 7 (1), 40-46, 2016
162016
Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand
JM Tordoff, NJ Ailabouni, DP Browne, HS Al-Sallami, AR Gray
International journal of clinical pharmacy 38, 941-949, 2016
112016
Medication use quality and safety in older adults: 2018 update
NJ Ailabouni, ZA Marcum, KE Schmader, SL Gray
Journal of the American Geriatrics Society 67 (12), 2458-2462, 2019
82019
Difficulty with Taking Medications Is Associated with Future Diagnosis of Alzheimer’s Disease and Related Dementias
D Barthold, ZA Marcum, S Chen, L White, N Ailabouni, A Basu, NB Coe, ...
Journal of General Internal Medicine 36, 863-868, 2021
72021
Can existing tools predict older adults' willingness to deprescribe? Considerations for D-PRESCRIBE's post-hoc secondary analysis
NJ Ailabouni, E Reeve
Research in social & administrative pharmacy: RSAP 15 (11), 1379-1380, 2019
72019
Considerations for systematic reviews of quantitative surveys: learnings from a systematic review of the patients’ attitudes towards deprescribing questionnaire
KR Weir, NJ Ailabouni, CR Schneider, SN Hilmer, E Reeve
Research in Social and Administrative Pharmacy 18 (2), 2345-2349, 2022
62022
Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older …
U Bergler, NJ Ailabouni, JW Pickering, SN Hilmer, D Mangin, PS Nishtala, ...
Trials 22, 1-12, 2021
52021
Consumer and healthcare professional led priority setting for quality use of medicines in people with dementia: Gathering unanswered research questions
E Reeve, L Chenoweth, M Sawan, TA Nguyen, L Kalisch Ellett, ...
Journal of Alzheimer's Disease 91 (3), 933-960, 2023
42023
Medication Use Quality and Safety in older adults: 2019 update
NJ Ailabouni, ZA Marcum, KE Schmader, SL Gray
Journal of the American Geriatrics Society 69 (2), 336-341, 2021
32021
系统目前无法执行此操作,请稍后再试。
文章 1–20